NCT06040125 - Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions

PROSTATE CANCERMetastatic Prostate CancerMetastatic Prostate Carcinoma

Interventions

BEHAVIORAL

Supervised Circuit Training

16-week, multicomponent exercise intervention comprised of sessions supervised by certified exercise oncology trainer and home-based, self-directed aerobic exercises. Stationary bike and accelerometer (activity/heart rate monitor) will be provided.

Trial Locations (3)

02215

NOT_YET_RECRUITING

Beth Israel Deaconess Medical Center, Boston

RECRUITING

Brigham and Women's Hospital, Boston

NOT_YET_RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors

collaborator

Prostate Cancer Foundation

OTHER

lead

Dana-Farber Cancer Institute

OTHER